Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (135K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (91)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Aldrian-Herrada, G.
Right arrow Articles by Rabie, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aldrian-Herrada, G.
Right arrow Articles by Rabie, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, Vol 26, Issue 21 4910-4916, Copyright © 1998 by Oxford University Press


ARTICLES

A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons

G Aldrian-Herrada, MG Desarmenien, H Orcel, L Boissin-Agasse, J Mery, J Brugidou and A Rabie
CNRS-UPR 9055, Biologie des Neurones Endocrines, CCIPE, 141 rue de la Cardonille, 34094 Montpellier Cedex 5, France.

A peptide nucleic acid (PNA) antisense for the AUG translation initiation region of prepro-oxytocin mRNA was synthesized and coupled to a r etro-inverso peptide that is rapidly taken up by cells. This bioconjugate was internalized by cultured cerebral cortex neurons within minutes, according to the specific property of the vector peptide. The PNA alone also entered the cells, but more slowly. Cell viability was unaffected when the PNA concentrations were lower than 10 microM and incubation times less than for 24 h. Magnocellular neurons from the hypothalamic supraoptic nucleus, which produce oxytocin and vasopressin, were cultured in chemically defined medium. Both PNA and vector peptide-PNA depressed the amounts of the mRNA coding for prepro- oxytocin in these neurons. A scrambled PNA had no effect and the very cognate prepro-vasopressin mRNA was not affected. The antisense PNA also depressed the immunocytochemical signal for prepro-oxytocin in this culture in a dose- and time-dependent manner. These results show that PNAs driven by the retro-inverso vector peptide are powerful antisense reagents for use on cells in culture.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CSH ProtocolsHome page
P. Lundberg, K. Kilk, and U. Langel
Cell-Penetrating Peptide-Mediated Delivery of Peptide Nucleic Acid (PNA) Oligomers
CSH Protocols, March 1, 2008; 2008(4): pdb.prot4889 - pdb.prot4889.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
T. Shiraishi and P. E. Nielsen
Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates
Nucleic Acids Res., September 15, 2004; 32(16): 4893 - 4902.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-i. Sakakibara, Y. Nakamura, T. Yoshida, S. Shibata, M. Koike, H. Takano, S. Ueda, Y. Uchiyama, T. Noda, and H. Okano
RNA-binding protein Musashi family: Roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation
PNAS, November 12, 2002; 99(23): 15194 - 15199.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
V. Rapozzi, B. E. A. Burm, S. Cogoi, G. A. van der Marel, J. H. van Boom, F. Quadrifoglio, and L. E. Xodo
Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids
Nucleic Acids Res., September 1, 2002; 30(17): 3712 - 3721.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. Kaushik, T. T. Talele, R. Monel, P. Palumbo, and V. N. Pandey
Destabilization of tRNA3Lys from the primer-binding site of HIV-1 genome by anti-A loop polyamide nucleotide analog
Nucleic Acids Res., December 15, 2001; 29(24): 5099 - 5106.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Mologni, E. Marchesi, P. E. Nielsen, and C. Gambacorti-Passerini
Inhibition of Promyelocytic Leukemia (PML)/Retinoic Acid Receptor-{alpha} and PML Expression in Acute Promyelocytic Leukemia Cells by Anti-PML Peptide Nucleic Acid
Cancer Res., July 1, 2001; 61(14): 5468 - 5473.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Bultmann, J. S. Busse, and C. R. Brandt
Modified FGF4 Signal Peptide Inhibits Entry of Herpes Simplex Virus Type 1
J. Virol., March 15, 2001; 75(6): 2634 - 2645.
[Abstract] [Full Text]


Home page
FASEB J.Home page
A. RAY and B. NORDÉN
Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future
FASEB J, June 1, 2000; 14(9): 1041 - 1060.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. C. Boffa, S. Scarfi’, M. R. Mariani, G. Damonte, V. G. Allfrey, U. Benatti, and P. L. Morris
Dihydrotestosterone as a Selective Cellular/Nuclear Localization Vector for Anti-Gene Peptide Nucleic Acid in Prostatic Carcinoma Cells
Cancer Res., April 1, 2000; 60(8): 2258 - 2262.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
G. L. Fraser, J. Holmgren, P. B. S. Clarke, and C. Wahlestedt
Antisense Inhibition of delta -Opioid Receptor Gene Function In Vivo by Peptide Nucleic Acids
Mol. Pharmacol., April 1, 2000; 57(4): 725 - 731.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.